Fundraising Fox

Augmenix

Waltham, US · Delaware corporation · 2 known investors

augmenix.com ↗
Biotech

Founders & leadership

JP
John PedersenExecutive
PC
Patrick CampbellExecutive
AS
Amarpreet SawhneyNamed on SEC filing

Board

FK
Farhad KhosraviBoard director
TB
Tara ButlerBoard directorManaging Director at Ascension Ventures
TDTasneem Dohadwala
Tasneem DohadwalaBoard directorFounding Partner at Excelestar Ventures

Investors · 2

Ascension VenturesSaint Louis · $10M – $20M
Excelestar VenturesreportedAndovervia Tasneem Dohadwala · board

Reported raises · per SEC filings

Form D private placements

$16.9M disclosed across 2 rounds · 2014–2016

▶$6MraisedJul 2016 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Farhad KhosraviDirector
  • Tara ButlerDirector
  • John PedersenExecutive Officer, Director
  • Tasneem DohadwalaDirector
  • Patrick CampbellExecutive Officer, Director
  • Amarpreet SawhneyDirector
Offering amount
$6M
Amount sold
$6M
First sale
Jul 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.9MraisedJul 2014 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick CampbellExecutive Officer, Director
  • Tara ButlerDirector
  • Tasneem DohadwalaDirector
  • Amarpreet SawhneyExecutive Officer, Director
  • Farhad KhosraviDirector
Offering amount
$10.9M
Amount sold
$10.9M
First sale
Jul 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Augmenix's investors?
Augmenix's investors include Ascension Ventures, Excelestar Ventures.
How much funding has Augmenix raised?
Augmenix has disclosed $16.9M raised across 2 rounds.
Where is Augmenix headquartered?
Augmenix is headquartered in Waltham, US.